<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00932425</url>
  </required_header>
  <id_info>
    <org_study_id>CMACS</org_study_id>
    <nct_id>NCT00932425</nct_id>
  </id_info>
  <brief_title>Long-term Cardiac Monitoring After Cryptogenic Stroke (CMACS)</brief_title>
  <acronym>CMACS</acronym>
  <official_title>Long-term Cardiac Monitoring After Cryptogenic Stroke (CMACS): A Pilot Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation (AF) is a common and treatable cause of ischemic stroke, but it can be
      paroxysmal and asymptomatic, and therefore difficult to detect. Patients with stroke
      routinely undergo 24 hours of continuous cardiac telemetry during hospitalization for stroke
      as a means of excluding AF. Small studies indicate that extending the duration of monitoring
      with portable outpatient telemetry devices detects more cases of AF. However, these studies
      are small and lack control groups, and cannot demonstrate that prolonged cardiac monitoring
      detects more cases of AF than routine clinical follow-up. The investigators therefore propose
      a pilot study to determine the feasibility of randomizing patients to prolonged cardiac
      monitoring or routine clinical follow-up. The investigators will enroll 40 consecutive adult
      patients seen at the University of California at San Francisco (UCSF) Neurovascular service
      with cryptogenic stroke or high-risk TIA (ABCD2 score 4 or greater). Enrolled patients will
      be randomized in a 1:1 fashion. Group A will be assigned to wear an ambulatory cardiac event
      monitor for 21 days. Group B will be discharged home without a monitor and will serve as
      controls during routine clinical follow-up. The investigators' primary outcome will be
      feasibility, defined as more than 80% of randomized patients completing full clinical
      follow-up and more than 70% of cardiac monitoring if applicable. The investigators' secondary
      outcomes will be diagnoses of AF at 90 days and 1 year and diagnoses of recurrent stroke at 1
      year.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Completion of Clinical Follow-up as a Measure of Feasibility</measure>
    <time_frame>1 year</time_frame>
    <description>Feasibility was defined as 90% or more of randomized patients completing full clinical follow-up and 70% or more completion of assigned cardiac monitoring if applicable</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Completion of Assigned Monitoring as a Measure of Feasibility</measure>
    <time_frame>21 days</time_frame>
    <description>Feasibility criteria included more than 70% completion of cardiac monitoring if applicable. Patients in the Monitoring arm were assigned to wear a Cardionet mobile cardiac outpatient telemetry monitor for 21 days. Outpatient monitoring began 22 days (+/- 12 days) after symptom onset.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnosis of Atrial Fibrillation</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnosis of Atrial Fibrillation</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrent Stroke or TIA</measure>
    <time_frame>1 year</time_frame>
    <description>Patients and their primary physicians or neurologists were contacted at 3 months and 1 year after discharge and reported clinical diagnoses of recurrent stroke or TIA using validated questionnaires. Reported events were verified by review of relevant medical records.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Outpatient cardiac monitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be assigned to wear a portable outpatient cardiac telemetry device for 21 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will be discharged home with standard clinical follow-up</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cardionet Mobile Cardiac Outpatient Telemetry (MCOT)</intervention_name>
    <description>Patients will be assigned to wear the telemetry device for 21 days</description>
    <arm_group_label>Outpatient cardiac monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Seen at UCSF Medical Center for cryptogenic stroke or high-risk TIA

          -  Onset of stroke or TIA symptoms within the previous 60 days

        Exclusion Criteria:

          -  Definite small-vessel etiology by history or imaging

          -  Source found on vascular imaging of possible culprit vessels

          -  Source found by echocardiography (TEE not required)

          -  History of atrial fibrillation

          -  Atrial fibrillation on admission ECG

          -  Atrial fibrillation detected by inpatient cardiac telemetry (at least 24 hours
             required)

          -  Obvious culpable systemic illness such as endocarditis

          -  Patient unable to provide written, informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wade Smith, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 1, 2009</study_first_submitted>
  <study_first_submitted_qc>July 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2009</study_first_posted>
  <results_first_submitted>February 12, 2015</results_first_submitted>
  <results_first_submitted_qc>February 12, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 27, 2015</results_first_posted>
  <last_update_submitted>February 12, 2015</last_update_submitted>
  <last_update_submitted_qc>February 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>Cryptogenic</keyword>
  <keyword>Cardioembolic</keyword>
  <keyword>Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>40 patients were enrolled between October 29, 2009 and May 24, 2011</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Outpatient Cardiac Monitoring</title>
          <description>Patients assigned to wear a portable outpatient cardiac telemetry device for 21 days
Cardionet Mobile Cardiac Outpatient Telemetry (MCOT): Patients will be assigned to wear the telemetry device for 21 days</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Patients discharged home with standard clinical follow-up</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>per protocol</population>
      <group_list>
        <group group_id="B1">
          <title>Outpatient Cardiac Monitoring</title>
          <description>Patients assigned to wear a portable outpatient cardiac telemetry device for 21 days
Cardionet Mobile Cardiac Outpatient Telemetry (MCOT): Patients will be assigned to wear the telemetry device for 21 days</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Patients discharged home with standard clinical follow-up</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
            <count group_id="B2" value="20"/>
            <count group_id="B3" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65" spread="15"/>
                    <measurement group_id="B2" value="69" spread="9"/>
                    <measurement group_id="B3" value="67" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Completion of Clinical Follow-up as a Measure of Feasibility</title>
        <description>Feasibility was defined as 90% or more of randomized patients completing full clinical follow-up and 70% or more completion of assigned cardiac monitoring if applicable</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Outpatient Cardiac Monitoring</title>
            <description>Patients assigned to wear a portable outpatient cardiac telemetry device for 21 days
Cardionet Mobile Cardiac Outpatient Telemetry (MCOT): Patients will be assigned to wear the telemetry device for 21 days</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients discharged home with standard clinical follow-up</description>
          </group>
        </group_list>
        <measure>
          <title>Completion of Clinical Follow-up as a Measure of Feasibility</title>
          <description>Feasibility was defined as 90% or more of randomized patients completing full clinical follow-up and 70% or more completion of assigned cardiac monitoring if applicable</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diagnosis of Atrial Fibrillation</title>
        <time_frame>90 days</time_frame>
        <population>2 patients in the control arm did not have a full 90 days of assessment (see Participant Flow)</population>
        <group_list>
          <group group_id="O1">
            <title>Outpatient Cardiac Monitoring</title>
            <description>Patients assigned to wear a portable outpatient cardiac telemetry device for 21 days
Cardionet Mobile Cardiac Outpatient Telemetry (MCOT): Patients will be assigned to wear the telemetry device for 21 days</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients discharged home with standard clinical follow-up</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnosis of Atrial Fibrillation</title>
          <population>2 patients in the control arm did not have a full 90 days of assessment (see Participant Flow)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diagnosis of Atrial Fibrillation</title>
        <time_frame>1 year</time_frame>
        <population>2 participants in the Control arm were followed for less than 90 days</population>
        <group_list>
          <group group_id="O1">
            <title>Outpatient Cardiac Monitoring</title>
            <description>Patients assigned to wear a portable outpatient cardiac telemetry device for 21 days
Cardionet Mobile Cardiac Outpatient Telemetry (MCOT): Patients will be assigned to wear the telemetry device for 21 days</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients discharged home with standard clinical follow-up</description>
          </group>
        </group_list>
        <measure>
          <title>Diagnosis of Atrial Fibrillation</title>
          <population>2 participants in the Control arm were followed for less than 90 days</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recurrent Stroke or TIA</title>
        <description>Patients and their primary physicians or neurologists were contacted at 3 months and 1 year after discharge and reported clinical diagnoses of recurrent stroke or TIA using validated questionnaires. Reported events were verified by review of relevant medical records.</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Outpatient Cardiac Monitoring</title>
            <description>Patients assigned to wear a portable outpatient cardiac telemetry device for 21 days
Cardionet Mobile Cardiac Outpatient Telemetry (MCOT): Patients will be assigned to wear the telemetry device for 21 days</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Patients discharged home with standard clinical follow-up</description>
          </group>
        </group_list>
        <measure>
          <title>Recurrent Stroke or TIA</title>
          <description>Patients and their primary physicians or neurologists were contacted at 3 months and 1 year after discharge and reported clinical diagnoses of recurrent stroke or TIA using validated questionnaires. Reported events were verified by review of relevant medical records.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>TIA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Completion of Assigned Monitoring as a Measure of Feasibility</title>
        <description>Feasibility criteria included more than 70% completion of cardiac monitoring if applicable. Patients in the Monitoring arm were assigned to wear a Cardionet mobile cardiac outpatient telemetry monitor for 21 days. Outpatient monitoring began 22 days (+/- 12 days) after symptom onset.</description>
        <time_frame>21 days</time_frame>
        <population>Only patients in the monitoring arm were assessed for compliance with assigned monitoring</population>
        <group_list>
          <group group_id="O1">
            <title>Outpatient Cardiac Monitoring</title>
            <description>Patients assigned to wear a portable outpatient cardiac telemetry device for 21 days
Cardionet Mobile Cardiac Outpatient Telemetry (MCOT): Patients will be assigned to wear the telemetry device for 21 days</description>
          </group>
        </group_list>
        <measure>
          <title>Completion of Assigned Monitoring as a Measure of Feasibility</title>
          <description>Feasibility criteria included more than 70% completion of cardiac monitoring if applicable. Patients in the Monitoring arm were assigned to wear a Cardionet mobile cardiac outpatient telemetry monitor for 21 days. Outpatient monitoring began 22 days (+/- 12 days) after symptom onset.</description>
          <population>Only patients in the monitoring arm were assessed for compliance with assigned monitoring</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>Participants were assessed for adverse events attributable to the intervention during the monitoring period, and for recurrent stroke or TIA at 3 months and 1 year</desc>
      <group_list>
        <group group_id="E1">
          <title>Outpatient Cardiac Monitoring</title>
          <description>Patients assigned to wear a portable outpatient cardiac telemetry device for 21 days
Cardionet Mobile Cardiac Outpatient Telemetry (MCOT): Patients will be assigned to wear the telemetry device for 21 days</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Patients discharged home with standard clinical follow-up</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>TIA</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Contact dermatitis</sub_title>
                <description>One participant in the monitoring group had contact dermatitis, which we classified as an AE attributable to the intervention.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="20"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Wade Smith, MD, PhD</name_or_title>
      <organization>University of California San Francisco</organization>
      <phone>415-353-8897</phone>
      <email>smithw@neurology.ucsf.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

